(0.26%) 5 145.00 points
(0.16%) 38 502 points
(0.40%) 17 917 points
(-0.62%) $83.33
(1.82%) $1.958
(-0.13%) $2 344.10
(-0.04%) $27.52
(2.86%) $948.50
(-0.01%) $0.935
(-0.05%) $11.02
(-0.23%) $0.799
(1.89%) $93.61
Live Chart Being Loaded With Signals
Golden Throat Holdings Group Company Limited, an investment holding company, manufactures and sells pharmaceutical, healthcare food, and other products in the People's Republic of China...
Stats | |
---|---|
Šios dienos apimtis | 117 000 |
Vidutinė apimtis | 243 688 |
Rinkos kapitalizacija | 2.74B |
EPS | HKD0 ( 2024-03-28 ) |
Last Dividend | HKD0.360 ( 2023-06-16 ) |
Next Dividend | HKD0 ( N/A ) |
P/E | 7.27 |
ATR14 | HKD0.0110 (0.30%) |
Golden Throat Holdings Koreliacija
10 Labiausiai teigiamai susiję koreliacijos |
---|
10 Labiausiai neigiamai susiję koreliacijos |
---|
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
Golden Throat Holdings Finansinės ataskaitos
Annual | 2023 |
Pajamos: | HKD961.38M |
Bruto pelnas: | HKD697.72M (72.57 %) |
EPS: | HKD0.340 |
FY | 2023 |
Pajamos: | HKD961.38M |
Bruto pelnas: | HKD697.72M (72.57 %) |
EPS: | HKD0.340 |
FY | 2022 |
Pajamos: | HKD992.01M |
Bruto pelnas: | HKD720.92M (72.67 %) |
EPS: | HKD0.380 |
FY | 2021 |
Pajamos: | HKD820.54M |
Bruto pelnas: | HKD577.74M (70.41 %) |
EPS: | HKD0.250 |
Financial Reports:
No articles found.
Golden Throat Holdings Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0.360 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | HKD0.0600 | 2016-05-26 |
Last Dividend | HKD0.360 | 2023-06-16 |
Next Dividend | HKD0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 10 | -- |
Total Paid Out | HKD1.140 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.61 | -- |
Div. Sustainability Score | 8.35 | |
Div.Growth Potential Score | 5.03 | |
Div. Directional Score | 6.69 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
87001.HK | Ex Dividend Junior | 2023-08-10 | Semi-Annually | 0 | 0.00% | |
2107.HK | Ex Dividend Junior | 2023-06-29 | Annually | 0 | 0.00% | |
1114.HK | Ex Dividend Junior | 2023-08-11 | Annually | 0 | 0.00% | |
0189.HK | Ex Dividend Junior | 2023-06-14 | Annually | 0 | 0.00% | |
3808.HK | Ex Dividend Junior | 2023-07-04 | Annually | 0 | 0.00% | |
1696.HK | Ex Dividend Junior | 2023-08-24 | Annually | 0 | 0.00% | |
0730.HK | Ex Dividend Junior | 2023-05-24 | Annually | 0 | 0.00% | |
2283.HK | Ex Dividend Knight | 2023-09-07 | Semi-Annually | 0 | 0.00% | |
1270.HK | Ex Dividend Knight | 2023-05-16 | Annually | 0 | 0.00% | |
0323.HK | No Dividend Player | 2023-06-21 | Sporadic | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.260 | 1.500 | 4.80 | 7.19 | [0 - 0.5] |
returnOnAssetsTTM | 0.109 | 1.200 | 6.37 | 7.65 | [0 - 0.3] |
returnOnEquityTTM | 0.168 | 1.500 | 9.25 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0.972 | -1.000 | 0.279 | -0.279 | [0 - 1] |
currentRatioTTM | 2.57 | 0.800 | 2.14 | 1.715 | [1 - 3] |
quickRatioTTM | 2.11 | 0.800 | 2.29 | 1.833 | [0.8 - 2.5] |
cashRatioTTM | 1.460 | 1.500 | 3.00 | 4.50 | [0.2 - 2] |
debtRatioTTM | 0.179 | -1.500 | 7.01 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 0 | 1.000 | -1.111 | -1.111 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.348 | 2.00 | 9.88 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.337 | 2.00 | 9.83 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.266 | -1.500 | 8.94 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.726 | 1.000 | 1.238 | 1.238 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.350 | 1.000 | 4.99 | 4.99 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.624 | 1.000 | 7.65 | 7.65 | [0.2 - 2] |
assetTurnoverTTM | 0.418 | 0.800 | -0.546 | -0.436 | [0.5 - 2] |
Total Score | 8.35 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 10.17 | 1.000 | 9.07 | 0 | [1 - 100] |
returnOnEquityTTM | 0.168 | 2.50 | 9.51 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.337 | 2.00 | 9.89 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 10.46 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.348 | 2.00 | 9.88 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.972 | 1.500 | 0.279 | -0.279 | [0 - 1] |
pegRatioTTM | 0 | 1.500 | -3.33 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.268 | 1.000 | 5.81 | 0 | [0.1 - 0.5] |
Total Score | 5.03 |
Golden Throat Holdings
Golden Throat Holdings Group Company Limited, an investment holding company, manufactures and sells pharmaceutical, healthcare food, and other products in the People's Republic of China. It offers Golden Throat lozenges over-the-counter medicine to relive symptoms of sore and dry throat, and hoarse voice caused by acute pharyngitis. It also provides Golden Throat lozenge series products that include Dule lozenges and sugar-free Dule lozenges in various flavors, such as orange, fructus momordicae, chrysanthemum, American ginseng, and hawthorn; Yinxingye tablet, which is designed to facilitate blood circulation, remove blood stasis, and dredge energy channels; and herbal vegetable beverages for soothing voice and relieving sore throats. The company also exports its products to the United States, Canada, Russia, the European Union, Australia, Southeast Asia, the Middle East, Mexico, and Africa. Golden Throat Holdings Group Company Limited was founded in 1956 and is headquartered in Liuzhou, the People's Republic of China.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.